<DOC>
	<DOCNO>NCT01158404</DOCNO>
	<brief_summary>The objective phase 1 study evaluate safety tolerability Notch Inhibitor patient advance cancer . This study include dose escalation dose confirmation component .</brief_summary>
	<brief_title>Notch Inhibitor Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>The patient must , judgment investigator , appropriate candidate experimental therapy available standard therapy cease provide clinical benefit disease . The patient must histological cytological evidence cancer , either solid tumor lymphoma , advance and/or metastatic . Have adequate organ function include : Hematologic : Absolute neutrophil count ( ANC ) ≥1.5 x 109/L , platelet ≥100 x 109/L , hemoglobin ≥8 g/dL . Hepatic : Bilirubin ≤1.5 time upper limit normal ( ULN ) alanine aminotransferase ( ALT ) ≤3.0 time ULN . Renal : Serum creatinine ≤1.5 time ULN . Have performance status less equal 1 Dose Escalation less equal 2 Dose Confirmation Eastern Cooperative Oncology Group ( ECOG ) scale . Have discontinue previous therapy cancer ( include chemotherapy , radiotherapy , immunotherapy , investigational therapy ) least 21 day myelosuppressive agent 14 day nonmyelosuppressive agent prior receive study drug , recover acute effect therapy ( treatmentrelated toxicity resolve baseline ) except residual alopecia . Males female reproductive potential must agree use medically approve contraceptive precaution trial 3 month follow last dose study drug . Females childbearing potential must negative serum pregnancy test within 7 day first dose study drug . Have receive treatment drug receive regulatory approval indication within 14 21 day initial dose study drug nonmyelosuppressive myelosuppressive agent , respectively . Have serious preexist medical condition , judgment investigator , would preclude participation study ( example , inflammatory bowel disease history major surgical resection involve stomach small bowel ) . Have malabsorptive syndrome , enteropathy , gastroenteritis ( acute chronic ) , diarrhea ( acute chronic ) . Females pregnant lactating . Have CNS malignancy metastasis . Have acute leukemia . Have active bacterial , fungal and/or know viral infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Metastatic Cancer</keyword>
	<keyword>Solid Tumors</keyword>
</DOC>